Paramectin Drench 0.08% w/v Oral Solution

País: Reino Unido

Idioma: inglés

Fuente: VMD (Veterinary Medicines Directorate)

Ingredientes activos:

Ivermectin

Disponible desde:

Norbrook Laboratories Limited

Código ATC:

QP54AA

Designación común internacional (DCI):

Ivermectin

formulario farmacéutico:

Oral solution

tipo de receta:

POM-VPS -Prescription Only Medicine – Veterinarian, Pharmacist, Suitably Qualified Person

Grupo terapéutico:

Sheep

Área terapéutica:

Endectocide

Estado de Autorización:

Authorized

Fecha de autorización:

2006-11-08

Ficha técnica

Revised: July 2018
AN: 02259/2017
Page 1 of 5
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Paramectin Drench 0.8 mg/ml Oral Solution
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
ACTIVE SUBSTANCE:
Ivermectin
0.8 mg/ml
EXCIPIENTS:
Benzyl alcohol
30 ml/ml
For the full list of excipients, see section 6.1
3.
PHARMACEUTICAL FORM
Oral solution
A pale yellow clear liquid
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Sheep
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Treatment and control of gastrointestinal nematodes, lungworms and
nasal bots of
sheep
GASTROINTESTINAL WORMS (ADULT AND IMMATURE):
_Haemonchus contortus, Ostertagia circumcincta,_ _ Trichostrongylus _
spp, _ Cooperia _
spp,
_Nematodirus _
spp
including
_N. _
_battus, _
_Strongyloides _
_papillosus_,_ _
_Oesophagostomum _spp, and adult _Chabertia ovina_
Inhibited larval stages and benzimidazole resistant strains of _ H.
contortus_ and
_Ostertagia circumcincta_ are also controlled.
LUNGWORMS_ _(ADULT AND IMMATURE):
_Dictyocaulus filaria_
NASAL BOT (ALL LARVAL STAGES):
_Oestrus ovis_
4.3
CONTRAINDICATIONS
The product has been formulated specifically for use in sheep. It
should not be used
in other species, as severe adverse reactions, including fatalities in
dogs, may occur.
Revised: July 2018
AN: 02259/2017
Page 2 of 5
Do not use in cases of hypersensitivity to the active substances or to
any of the
excipients.
The product is not for intravenous or intramuscular use.
Do not use in sheep producing milk for human consumption.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
Care should be taken to avoid the following practices because they
increase the risk
of development of resistance and could ultimately result in
ineffective therapy:
•
Too frequent and repeated use of anthelmintics from the same class,
over an
extended period of time.
•
Underdosing
which
may
be
due
to
underestimation
of
body
weight,
misadministration of the product, or lack of calibration of the dosing
device (if
any).
Suspected clinical cases of resist